
Candy Recall Update as FDA Sets Risk Level
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The Food and Drug Administration (FDA) has classified a Dinstuhl's Fine Candy Company Inc. voluntary recall, that was initiated after undeclared allergens were found in several candy products.
The Tennessee-based candy manufacturer started the recall after finding that milk was in three of its confections without the allergen being labeled on the products' descriptions.
Newsweek has contacted Dinstuhl's Fine Candy Company Inc. out of regular working hours via email for comment.
Why It Matters
Undeclared allergens pose serious health risks to individuals with allergies. According to the FDA, milk is one of the nine major food allergens that must be declared on packaging under federal labeling laws. The others are eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans and sesame.
Consumption of a product containing undeclared milk could trigger allergic reactions ranging from mild symptoms to life-threatening anaphylaxis.
A photo of Dinstuhl's Cashew Crunch candy, one of the products affected by the recall.
A photo of Dinstuhl's Cashew Crunch candy, one of the products affected by the recall.
Dinstuhl's Fine Candy Company
What To Know
The recall, which began on March 4, 2025, affects limited quantities distributed to three retailers in Missouri and Mississippi.
As of May 1, the FDA has classified the situation as a Class II recall, meaning the products could cause temporary or medically reversible health consequences, though the probability of serious adverse health consequences is remote.
The recalled products, each packaged in 4-ounce cellophane bags, are:
Dinstuhl's Cashew Crunch (UPC: 7 68050 01919 8) — 24 units
Dinstuhl's Peanut Brittle (UPC: 7 68050 00205 3) — 12 units
Dinstuhl's Pecan Brittle (UPC: 7 68050 00755 3) — 12 units
All products have an expiration date of June 15, 2025, and the batch number R15. The recall is still ongoing.
Other Candy Recalls This Year
It's not the first time this year that candy has been subject to recall. Candy sold in eight states was pulled from store shelves in April because of the presence of undeclared color additives.
The recall, initiated by Blooming Import Inc. in Brooklyn, New York, affected 74 cases of Golden Crop Candy, which included the dyes Blue 1, Red 40 and Acid Red 18, which were not listed on the product label.
A firm based in Portland, Oregon, The Candy Basket Inc., also recalled its orange, lemon, marionberry and raspberry jelly sticks in January due to the presence of the undeclared allergens: Yellow 6, Sodium Benzoate, Yellow 5, Potassium Sorbate, Red 3, Blue 1, Propylene Glycol and Red 40.
While not classified as major allergens, food additives like Yellow 6 can trigger sensitivities or allergic-like reactions in some individuals.
Earlier this year, Gardners Candies also voluntarily recalled its Cappuccino Meltaway bars because they may have contained cashew nuts, meaning the product posed a danger to those with tree-nut allergies.
What People Are Saying
Clinton Mathias, an associate professor in the Department of Nutritional Sciences at the University of Connecticut, previously told Newsweek: "Cow's milk allergy is the most common allergy affecting infants and children in the U.S. It is estimated that about 0.5-3 percent of children under the age of 3 have experienced allergy to milk proteins. While most children, between 40 and 57 percent, outgrow allergy to milk by school age, it is still among the most common food allergies in adults, with about 1.9 percent of adults reporting allergies to milk."
He added: "Symptoms of allergy to cow's milk can vary from person to person, with some people experiencing mild symptoms such as hives and others exhibiting severe reactions such as anaphylaxis. Other symptoms of milk allergy can include vomiting, diarrhea, rectal bleed, lethargy, etc."
What Happens Next
Consumers who purchased the Dinstuhl's products are urged not to consume them and to return them to the place of purchase or dispose of them.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
New test could transform diagnosis and treatment of STIs
A new rapid test for sexually transmitted infections could soon transform on-the-spot diagnosis and treatment. Birmingham-based Linear Diagnostics has secured £1 million in funding to develop the technology, which could deliver results in less than 20 minutes. The funding comes from the NIHR Invention for Innovation programme and will support a three-year project to finalise the test and prepare it for clinical trials. Dr Jean-Louis Duprey, head of research and development at Linear Diagnostics, said: "We are developing a near patient device that will overcome this conundrum." The company is working with the NIHR HealthTech Research Centre and the North East Innovation Lab to deliver the project. Dr Jana Suklan, senior methodologist at the HRC, said: "The NIHR HRC in Diagnostic and Technology Evaluation is delighted to be collaborating with the North East Innovation Lab to support Linear Diagnostics with their exciting technology. "Our research involves analysing unmet needs, examining current practice and identifying the most promising point in the patient pathway for implementing the technology." The test uses Linear's Exponential Amplification (EXPAR) technology, which detects bacterial DNA within minutes. The company has focused on STIs such as Neisseria gonorrhoeae and Chlamydia trachomatis, where rapid diagnosis is essential to prevent further transmission and begin treatment immediately.
Yahoo
7 hours ago
- Yahoo
Fitness Trainer Didn't Go to the Doctor for 7 Years Despite Strange Symptoms. Turns Out, She Had a Cyst the Size of a Baby (Exclusive)
Megan Johnson is a personal trainer from Chattanooga, Tenn. The 28-year-old self-diagnosed herself with diastasis recti, the separation of the rectus abdominis muscles, after not seeing a doctor in years After sharing her story online, Johnson realized her symptoms required medical attentionApart from visiting an optometrist, Megan Johnson hadn't seen a primary care doctor or gynecologist in nearly seven years. With no health insurance, a fear of medical bills, and a history of negative experiences with doctors, the personal trainer avoided seeking professional help. Trusting in her own judgment and online research, the 28-year-old from Chattanooga, Tenn., thought she had uncovered the main cause of her symptoms: diastasis recti. It wasn't until she shared her story on TikTok that everything began to shift as followers flooded her comments with concern and encouragement to seek real answers. What she discovered after finally taking herself to the emergency room left her stunned, but somehow relieved. 'My stomach was getting bigger and just wider,' Johnson tells PEOPLE exclusively. She first began noticing minor changes in 2021 after forming a cyst, which ended up rupturing. Two years later, she started experiencing severe bloating and painful periods as well as weight gain around her stomach. She realized something was off when her belly button started shifting from an innie to an outie, and the middle of her abdomen seemed to split. Curious to know more about her symptoms, she searched the internet and discovered diastasis recti – a condition where rectus abdominis muscles separate, according to the Cleveland Clinic. After learning how to test at home using a two-finger method, Johnson was convinced diastasis recti was to blame for her symptoms. She became determined to manage the condition as best she could on her own. She avoided both gynecologists and regular doctors due to past experiences where she felt dismissed. After losing health insurance through her parents, and later at her job, she chose not to renew her coverage. 'I just felt like it was a waste of money and so I just stopped going,' Johnson reveals. Over time, she started to believe that diastasis recti, coupled with visceral fat storage and hormonal imbalance, were causing changes to her body. In less than a year, Johnson had gained over 10 pounds and could no longer fit into her old clothes. However, over a five- to six-month span, she began noticing drastic growth around her abdomen, leaving her unrecognizable and filled with self-doubt, especially in her career as a physical trainer. Johnson ate healthy and weight trained, but despite doing everything "right," nothing seemed to work. That disconnect left her feeling like a 'fraud.' 'Feeling like I'm not able to help myself makes me feel unqualified to help other people,' Johnson admits. 'It was definitely something that knocked my confidence a lot.' In April 2025, she took to TikTok to discuss her struggles in hopes of getting some outside opinions. Almost immediately, online strangers flooded Johnson's video with their thoughts, with some even questioning whether she was pregnant. The comments provided a much-needed wake-up call, and it was then that she realized diastasis recti might not be the sole root of her health problems. 'It was insane. This army of women came to my rescue, you know, saying, 'this is exactly what I experienced. You look like me whenever I had that,'' she recalls. 'So once I got confirmation from other people, it gave me the confidence to be like, okay, you know what? This actually might be a bigger issue than I thought. I'm gonna go get it checked out.' As followers became more invested in her health journey, Johnson continued to document the entire experience on TikTok. She started by taking them on a trip to the emergency room on May 1st. 'This is not anybody's fault but my own,' Johnson said in a TikTok video while packing to leave for the ER. 'My own pride got in the way of me getting help because I would justify my symptoms - 'like nothing's wrong with me and I know best.' ' After a number of tests and scans, it was confirmed that she did have diastasis recti. However, she was also diagnosed with an ovarian cyst close to the size of a newborn baby. Johnson read the results out loud in a video, stating that she had a 'massive cystic mass extending from the left upper quadrant to the floor of the pelvis measuring up to 48 centimeters.' With the news, many followers questioned why she hadn't seen a doctor sooner. She likened her health journey to a 'toxic relationship,' noting how it's easy to think everything is fine when change happens over time. Things didn't fall apart overnight, but through small changes that added up. By the time she noticed, it was clear something had to change. 'Ya'll are really giving me a reality check,' she said in a video responding to comments. 'I feel like I have a bunch of big sisters that are getting on to me but in a loving way – calling me in, not calling me out – and I hear you.' With the help of social media, Johnson was able to find the confidence to see a gynecologic oncologist, who decided the best course of action would be to surgically remove the cyst. Instead of feeling overwhelmed, the trainer felt relieved. 'I have some satisfaction…because I know that the thing that I've been dealing with for the past four years, that I thought I would be struggling with for the rest of my life, there's a solution, and, like, one day I won't have to struggle with it,' she tells PEOPLE. Throughout her journey, Johnson has remained committed to staying positive online. She tried to make light of the situation by making sex reveal cupcakes and naming her large mass, 'Cysterella." 'I really feel like, no matter how it turns out, it's going to serve a bigger purpose than just me and that gives me a lot of hope,' she shares. Much of her energy and optimism comes from her strong faith. Johnson believes that every experience, whether good or bad, has the potential to lead to a meaningful takeaway. On May 22, Johnson underwent a successful surgery with 27 pounds of fluid being drained out of her body. Unfortunately, the doctors had to remove an ovary and a fallopian tube in the process of pulling out the cyst, which Johnson knew was a possibility. Regarding her diastasis recti, Johnson's doctors are hoping it heals over time, especially now that the main cause of all her issues has been resolved. By sharing her story, she remains hopeful that others will learn from it and use it as an opportunity to self-reflect on their own health journeys. 'Don't suffer in silence,' Johnson emphasizes. 'Don't just sit back and hide your shame or embarrassment about what's going on with your body because most people are doing the best that they can, and we can't help it.' Johnson has decided that she will keep up with her yearly checkups and keep a closer eye on her health. 'I've seen so many other comments of people saying that they are now scheduling appointments where they're gynecologists or the doctor or the specialist or whoever because of me, and because of that, it makes all of this worth it,' she said in a TikTok video. 'If I had to go back and go through everything that I did for the same result, I absolutely would," she added. "And now that I know better, I'm gonna do better.' Read the original article on People
Yahoo
9 hours ago
- Yahoo
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data